The Role of O-GlcNAcylation in the Development of Idiopathic Pulmonary Fibrosis

Awarded in 2025
Updated Sep 29, 2025

At a Glance

Idiopathic pulmonary fibrosis (IPF) and related fibrotic lung diseases are life threatening, with limited treatment options and high mortality, leading to approximately 1,000 deaths annually in Wisconsin. This project investigates a promising new signaling pathway in the development of lung fibrosis involving protein modification to explore how a particular enzyme contributes to lung scarring and disease progression. The project team aims to uncover key fibrotic signaling pathways that could lead to more targeted therapies for IPF and other fibrotic diseases without affecting essential biological functions.

Collaborators: Ksenija Bernau, PhD, assistant professor, Department of Medicine